StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.06−0.53 (-4.21%)

Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –

Pharming operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was $54.71M. The highest annual figure on record is $83.63M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$54.71M–
FY2024Dec 31, 2024-$1.80M–
FY2023Dec 31, 2023-$17.30M-177.0%
FY2022Dec 31, 2022$22.46M-40.7%
FY2021Dec 31, 2021$37.84M-54.7%
FY2020Dec 31, 2020$83.63M+12.8%
FY2019Dec 31, 2019$74.15M–

More Pharming figures

See a number that looks wrong?